Chargement en cours...
Patterns of ranibizumab and aflibercept treatment of central retinal vein occlusion in routine clinical practice in the USA
BACKGROUND: The intravitreal anti-vascular endothelial growth factor treatments ranibizumab and aflibercept have proven efficacy in clinical trials, but their real world usage in central retinal vein occlusion (CRVO) has not been assessed. We therefore evaluated the treatment patterns of both drugs...
Enregistré dans:
| Publié dans: | Eye (Lond) |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4366471/ https://ncbi.nlm.nih.gov/pubmed/25572584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2014.308 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|